DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas

被引:11
|
作者
Itoh, Sachie [2 ]
Matsuoka, Hisafumi [1 ]
Yasuda, Yuki [2 ]
Miyake, Nobuka [2 ]
Suzuki, Keiko [2 ]
Yorifuji, Tohru [3 ]
Sugihara, Shigetaka [2 ]
机构
[1] Tokyo Womens Med Univ Med Ctr East, Dept Pediat, Arakawa Ku, Tokyo 1168567, Japan
[2] Tokyo Womens Med Univ Med Ctr East, Dept Pediat, Tokyo 1168567, Japan
[3] Osaka City Gen Hosp, Dept Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka, Japan
来源
关键词
DEND; K CNJ11; monogenic diabetes; sulfony lureas; V59A; NEONATAL DIABETES-MELLITUS; ACTIVATING MUTATIONS; KIR6.2; THERAPY;
D O I
10.1515/jpem-2012-0236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heterozygous activating mutations of KCNJ11 (Kir6.2) are the most common cause of permanent neonatal diabetes mellitus (NDM), and successful glycemic control has been obtained in several cases with oral sulfonylureas (SU). We have verified a lack of clinical response for both glycemic control and neurological features in an infant with permanent neonatal diabetes mellitus and DEND syndrome due to a V59A mutation in the KCNJ11 gene. Thus, our case reinforces that most cases with DEND syndrome are insensitive to SU.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation
    Barash, Galia
    Bassan, Haim
    Livne, Ayelet
    Benyamini, Lilach
    Heyman, Eli
    Bowman, Pamela
    Rachmiel, Marianna
    ACTA DIABETOLOGICA, 2021, 58 (12) : 1665 - 1672
  • [22] Neonatal Diabetes Mellitus Responsive to Sulphonylurea, Due to KCNJ11 Mutation
    Erbes, J. M.
    Garcia, T. S.
    Lee, J. S.
    Cechinel, E.
    Simoni, G.
    Nascimento, M. L.
    Silva, P. C. A.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 38 - 39
  • [23] Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene
    Vendramini, Marcio F.
    Gurgel, Lucimary C.
    Moises, Regina S.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (08) : 682 - 684
  • [24] KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
    Javorsky, Martin
    Klimcakova, Lucia
    Schroner, Zbynek
    Zidzik, Jozef
    Babjakova, Eva
    Fabianova, Maria
    Kozarova, Miriam
    Tkacova, Ruzena
    Salagovic, Jan
    Tkac, Ivan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 245 - 249
  • [25] Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene
    Joshi, Rajesh
    Phatarpekar, Ankur
    WORLD JOURNAL OF PEDIATRICS, 2011, 7 (04) : 371 - 372
  • [26] Analysis of Two KCNJ11 Neonatal Diabetes Mutations, V59G and V59A, and the Analogous KCNJ8 I60G Substitution DIFFERENCES BETWEEN THE CHANNEL SUBTYPES FORMED WITH SUR1
    Winkler, Marcus
    Lutz, Rebekka
    Russ, Ulrich
    Quast, Ulrich
    Bryan, Joseph
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (11) : 6752 - 6762
  • [27] Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature
    He, Binbin
    Li, Xia
    Zhou, Zhiguang
    JOURNAL OF DIABETES, 2021, 13 (01) : 19 - 32
  • [28] Case of family neonatal diabetes with KCNJ11 gene mutation: dynamics monitoring
    Chumak, Svitlana
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 540 - 540
  • [29] A novel mutation of KCNJ11 gene in a patient with permanent neonatal diabetes mellitus
    Chang, Wei-Lun
    Huang, Chun-Jui
    Lei, Tsun-Hsiang
    Niu, Dau-Ming
    Chiu, Chih-Yang
    Jap, Tjin-Shing
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (01) : E29 - E32
  • [30] Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
    Doneray, Hakan
    Houghton, Jayne
    Tekgunduz, Kadir Serafettin
    Balkir, Ferat
    Caner, Ibrahim
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (3-4): : 367 - 371